Immune Design Corp.
SEC CIK 1437786 · IMDZ · last insider filing 2019-04-04
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Baltimore David | Director | filed 2014 - 2019 |
| Penhoet Edward | Director | filed 2014 - 2019 |
| Coleman Lewis W | Director | filed 2015 - 2019 |
| Ringo William R | Director | filed 2014 - 2019 |
| Berger Franklin M | Director | filed 2014 - 2019 |
| Kelley Susan L. | Director | filed 2016 - 2019 |
| Paya Carlos V | Director · President and CEO | filed 2014 - 2019 |
| Svennilson Peter | Director | filed 2014 - 2019 |
| Atwood Brian G | Director | filed 2014 - 2016 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Gombotz Wayne | Chief Development Officer | filed 2014 - 2019 |
| ter Meulen Jan Henrik | Chief Scientific Officer | filed 2014 - 2019 |
| Brady Stephen R | EVP, Strategy & Finance | filed 2014 - 2019 |
| Yurasov Sergey | Sr. VP, Clinic. Devel. & CMO | filed 2016 - 2019 |
| Kenney Richard T | Chief Medical Officer | filed 2014 - 2016 |
| Rickey James Paul | VP, Finance and Administration | filed 2014 - 2015 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.